BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10483869)

  • 1. Expression and function of CD30 on T lymphocytes.
    Tarkowski M
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):217-21. PubMed ID: 10483869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms.
    Toennies HM; Green JM; Arch RH
    J Leukoc Biol; 2004 Feb; 75(2):350-7. PubMed ID: 14634058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30: expression and function in health and disease.
    Horie R; Watanabe T
    Semin Immunol; 1998 Dec; 10(6):457-70. PubMed ID: 9826579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of immune responses by the ligands for CD27, CD30, and 4-1BB.
    Alderson MR
    Circ Shock; 1994 Oct; 44(2):73-6. PubMed ID: 7743603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells.
    D'Elios MM; Romagnani P; Scaletti C; Annunziato F; Manghetti M; Mavilia C; Parronchi P; Pupilli C; Pizzolo G; Maggi E; Del Prete GF; Romagnani S
    J Leukoc Biol; 1997 May; 61(5):539-44. PubMed ID: 9129201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
    Croft M
    Nat Rev Immunol; 2003 Aug; 3(8):609-20. PubMed ID: 12974476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF family ligands define niches for T cell memory.
    Sabbagh L; Snell LM; Watts TH
    Trends Immunol; 2007 Aug; 28(8):333-9. PubMed ID: 17597006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies.
    Kroczek R; Hamelmann E
    J Allergy Clin Immunol; 2005 Oct; 116(4):906-9. PubMed ID: 16210068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
    Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
    Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.
    Flórido M; Borges M; Yagita H; Appelberg R
    J Leukoc Biol; 2004 Nov; 76(5):1039-46. PubMed ID: 15316035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 expression on allergen- and non-allergen-specific T cell lines and its role in cytokine production.
    Tarkowski M
    Arch Immunol Ther Exp (Warsz); 2003; 51(5):335-43. PubMed ID: 14626433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD30 in the pathogenesis of haematopoietic malignancies.
    Al-Shamkhani A
    Curr Opin Pharmacol; 2004 Aug; 4(4):355-9. PubMed ID: 15251128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-alpha-induced apoptosis in neonatal lymphocytes: TNFRp55 expression and downstream pathways of apoptosis.
    Aggarwal S; Gollapudi S; Yel L; Gupta AS; Gupta S
    Genes Immun; 2000; 1(4):271-9. PubMed ID: 11196704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy.
    Younes A; Kadin ME
    J Clin Oncol; 2003 Sep; 21(18):3526-34. PubMed ID: 12972530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications.
    de Bruin PC; Gruss HJ; van der Valk P; Willemze R; Meijer CJ
    Leukemia; 1995 Oct; 9(10):1620-7. PubMed ID: 7564499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene structure and chromosomal localization of the mouse homologue of rat OX40 protein.
    Birkeland ML; Copeland NG; Gilbert DJ; Jenkins NA; Barclay AN
    Eur J Immunol; 1995 Apr; 25(4):926-30. PubMed ID: 7737295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
    Cheuk AT; Mufti GJ; Guinn BA
    Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Messengers of cell death: apoptotic signaling in health and disease.
    Rossi D; Gaidano G
    Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.